Editors:
- Highlights innovative opportunities in drug discovery
- Overview of strategies and screening methods
- Compilation of current applicable technology
- Includes supplementary material: sn.pub/extras
Part of the book series: Progress in Drug Research (PDR, volume 66)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (9 chapters)
-
Front Matter
-
Back Matter
About this book
The use of substances derived from plants, fungi, bacteria and marine organisms has a long tradition in medicine. Together with their derivatives, and synthetic compounds deduced from natural product precursors, they represent a major part of today's pharmaceutical market.
In molecular biological research, natural products also play an important role as tool compounds in pathway screening and validation of target identification concepts. They provide innovative opportunities in drug discovery, leading to a detailed understanding of biological pathways and revealing the functions of involved enzymes or receptors.
This book highlights the biodiversity-driven approaches which are now of eminent importance in natural products research. It addresses the question why natural products display such a complex chemical information, what makes them often unique and what their characteristics are. Practical questions such as supply of natural substances and production optimization strategies are also covered.
Reviews
From the reviews:
“This second compilation highlights innovative trends in natural products research. … provide very diverging aspects from molecular biology to practical questions such as production optimization strategies. … This well-designed volume provides reviews of constant quality in the important field of modern drug research written by an international crew of experts. … Figures / schemes (numerous formulas) and tables are useful and well organized. … I recommend this book to anyone interested in modern drug research. It would best be suited for science and industry libraries.” (Eckart Eich, Economic Botany, Vol. 63 (4), 2009)Editors and Affiliations
-
Novartis Pharma AG, Basel, Switzerland
Frank Petersen, René Amstutz
Bibliographic Information
Book Title: Natural Compounds as Drugs, Volume II
Editors: Frank Petersen, René Amstutz
Series Title: Progress in Drug Research
DOI: https://doi.org/10.1007/978-3-7643-8595-8
Publisher: Birkhäuser Basel
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Birkhäuser Basel 2008
Hardcover ISBN: 978-3-7643-8594-1Published: 13 March 2008
eBook ISBN: 978-3-7643-8595-8Published: 29 July 2008
Series ISSN: 0071-786X
Series E-ISSN: 2297-4555
Edition Number: 1
Number of Pages: X, 428
Number of Illustrations: 185 b/w illustrations, 27 illustrations in colour